Concepedia

Publication | Open Access

EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients

80

Citations

20

References

2013

Year

Abstract

EGFR mutations detected on cytology specimens by a centralized laboratory can predict TKI treatment response equally well as mutations identified on histology samples.

References

YearCitations

Page 1